Napo Pharma

Develops small molecule therapeutics for diarrheal diseases

placeSan Francisco, California, United States calendar_todayFounded 2001 groups7 employees language napopharma.com

Registered entities

Social engagement

Social engagement: 4.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital240%
Private equity120%
Accelerator & incubator120%
Other / undisclosed120%

Recent activity

30 Jun 2026
Event
ESPGHAN 2026
12 Jun 2026
Event
Life Sciences Virtual Investor Forum
20 May 2026
Event
Japan Health to Hold Investor Webcast
Coming soon